Effects of individual inhalation of aerosolized amantadine hydrochloride in mice infected with influenza virus A/Bethesda 10/63 (H2N2) and A/Hong Kong 1/68 (H3N2).
D000281:Administration, Intranasal; D000284:Administration, Oral; D000336:Aerosols; D000547:Amantadine / Q000008:administration & dosage* / Q000627:therapeutic use; D000818:Animals; D004334:Drug Administration Schedule; D004864:Equipment and Supplies; D005260:Female; D053121:Influenza A Virus, H2N2 Subtype; D053122:Influenza A Virus, H3N2 Subtype; D009980:Influenza A virus; D008722:Methods; D051379:Mice; D009976:Orthomyxoviridae Infections / Q000188:drug therapy*; D014867:Water
D000336:Aerosols; D014867:Water; D000547:Amantadine